Navigation Links
3SBio Inc. Announces Unaudited Second Quarter Results
Date:8/17/2010

enue guidance -- New plant is granted GMP certification by SFDA

3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "the Company"), a leading China- based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced its unaudited financial results for the second quarter ended June 30, 2010.

Second Quarter 2010 Financial Highlights: -- Total net revenues increased by 29.5% over the second quarter of 2009 to RMB105.5 million (US$15.6 million). -- Operating income increased by 8.2% over the second quarter of 2009 to RMB27.9 million (US$4.1 million). -- Net income decreased by 5.4% over the second quarter of 2009 to RMB25.5 million (US$3.8 million) on a GAAP basis, and increased by 0.6% over the second quarter of 2009 to RMB25.5 million (US$3.8 million) on a non-GAAP basis. -- Net income per American Depositary Share ("ADS") on a fully-diluted basis for the second quarter of 2010 was RMB1.16 (US$0.17) compared with RMB1.25 (US$0.18) for the second quarter of 2009 on a GAAP basis, and RMB1.16 (US$0.17) for the second quarter of 2010 compared with RMB1.18 (US$0.17) for the second quarter of 2009 on a non-GAAP basis. First Half 2010 Financial Highlights: -- Total net revenues in the first half of 2010 increased by 34.5% to RMB201.9 million (US$29.8 million) compared to RMB150.1 million (US$22.0 million) in the first half of 2009. -- Operating income increased by 22.3% over the first half of 2009 to RMB56.1 million (US$8.3 million). -- Net income increased by 21.7% over the first half of 2009 to RMB52.2 million (US$7.7 million) on a GAAP basis, and increased by 13.7% over the first half of 2009 to RMB52.2 million (US$7.7 million) on a non-GAAP basis. -- Net income per ADS on a fully-diluted basis for the first half of 2010 was RMB2.37 (US$0.35) compared with RMB1.99 (US$0.29) for the first half of 2009 on a GAAP basis, a
'/>"/>

SOURCE 3SBio Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. 3SBio Inc. Announces Second Quarter 2008 Results
2. 3SBio Inc. to Hold Annual General Meeting
3. 3SBio Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference
4. 3SBio Inc. Announces Results of Annual General Meeting
5. 3SBio Inc. to Present at the UBS Global Life Sciences Conference
6. 3SBio Inc. Files for SFDA Approval of High-dose (36,000 IU) EPIAO
7. 3SBio Inc. Schedules 2008 Third Quarter Earnings Release on Monday, November 10, 2008
8. 3SBio Inc. Announces Preliminary Third Quarter 2008 Results
9. 3SBio Inc. Files for SFDA Approval of NuLeusin
10. 3SBio Inc. Announces Third Quarter 2008 Results
11. 3SBio Inc. to Present at the Piper Jaffray 20th Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 2015  Actavis plc (NYSE: ACT ) today ... Appeals for the Second Circuit has issued a ruling ... Company to continue distribution of NAMENDA ® (memantine ...   "While we are disappointed by ... to continue our strong efforts to convey the significant ...
(Date:5/22/2015)... NJ (PRWEB) May 22, 2015 ... new white paper that explores the potential of big ... The white paper was developed to help life sciences ... can leverage data to gain critical business insights. , ... large amounts of data driven by patient profiling, compliance ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 Seventh Wave ... safety and efficacy of pharmaceutical products and medical devices, ... Heights, MO 63043, a 50,000 sq. ft. building more ... to enable strategic growth. Facility renovations will begin immediately ... new space will occur in September. , “We ...
(Date:5/21/2015)... YORK , May 21, 2015  Prima Biomed ... company that is striving to become a leader in ... cancer, recently announced that the final CVac data from ... shown a clear trend for a clinically meaningful improvement ... in second remission patients. In the group ...
Breaking Biology Technology:Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 2Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 3Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 4Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 5Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 6Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 7Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 8New White Paper Explores the Potential of Big Data Analytics in Life Sciences and Healthcare 2Seventh Wave Laboratories Purchases Building for Expansion, Upcoming Move 2Seventh Wave Laboratories Purchases Building for Expansion, Upcoming Move 3Correction Continues after Big Move - BrokerBank Securities, Inc. 2
... MATEO, Calif., Feb. 4 NeurogesX, Inc. (Nasdaq: ... and commercializing novel pain management therapies, announced today that ... to present at the 11th Annual BIO CEO & ... 10, 2009. Mr. DiTonno and Stephen Ghiglieri, Chief Financial ...
... Genesis HealthCare, a provider of long-term care ... announced today that Wendy LaBate has been promoted to ... In her new position, LaBate will be responsible ... Genesis, Regional Vice Presidents of Operations and Administrators in ...
... Mich., Feb. 4 Diplomat Specialty Pharmacy is,pleased ... As of January 2009, DSP launched both ... Scott Reed has joined Diplomat as National,Sales Manager ... Indiana University and,has over 18 years ...
Cached Biology Technology:NeurogesX to Present at 11th Annual BIO CEO & Investor Conference 2NeurogesX to Present at 11th Annual BIO CEO & Investor Conference 3Genesis HealthCare Promotes Wendy LaBate To Senior Vice President of Operations for the Northeast Area 2Diplomat Specialty Pharmacy Expands National Hemophilia & IVIG Program 2
(Date:4/17/2015)... 2015 Increasing adoption ... advancement to drive biometric systems market in ... According to a recently released TechSci ... ", biometric systems market in Saudi ... at CAGR of over 22% through 2020. The ...
(Date:4/13/2015)... 2015 According to a ... Market Forecast & Opportunities, 2020", the global biometrics market ... 14% till 2020. The biometrics market is garnering ... and review of biometric management systems. The constant ... with greater efficiency, are resulting in increasing installation ...
(Date:4/9/2015)... , April 9, 2015 Synaptics Inc. (NASDAQ: ... solutions, announced today that it will report financial results ... April 23, 2015, after the close of market. The ... and investors at 2:00 p.m. PT (5:00 p.m. ET), ... To participate on the live call, analysts and ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2Synaptics to Report Third Quarter Results on April 23 2
... temperate forests across the United States, choking out native ... of Illinois ecologist Adam Davis has created a computer ... believes will be able to predict the perfect predator ... forested area that will help reduce the garlic mustard ...
... The Wildlife Conservation Society and the Panthera Foundation ... from Bhutan to Burma that would allow tiger populations ... at the United Nations on January 30th, would span ... habitat left on earth. , Dr. Alan Rabinowitz, ...
... A new thesis from he Swedish medical university Karolinska ... men and women. The scientists who conducted the study ... why depression and chronic anxiety are more common in ... brain neurotransmitter that is critical to the development and ...
Cached Biology News:Predicting the perfect predator 2Predicting the perfect predator 3'Genetic corridors' are next step to saving tigers 2'Genetic corridors' are next step to saving tigers 3
casein kinase 2, alpha 1 polypeptide, transcript variant 2, mRNA (cDNA clone MGC:15232 IMAGE:4121882), complete cds...
... complementary RNA Spikes for the normalization and ... array printing and for protocol assessment and ... hybridization stringency and background. Normalize Cy3 and ... Oligo Spots, and complementary RNA Spikes for ...
Kit for Detection of Mitochondrial Membrane Potential...
EGTA, 50 g. Ethylene glycol-O,O-bis-[2-amino-ethyl]-N,N,N,N,-tetraacetic acid.Assay: > 99.0%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Biology Products: